Linkedin
Facebook
Email
moreRSM, the 6th largest global network in advisory and audit, carried out financial, legal, and human resources buy-side due diligence for ProductLife Group, a global provider of regulatory, scientific, compliance, and digital transformation consulting services for the life sciences industry, during the acquisition of Outcomes’10, a Spanish life sciences consulting company specializing in patient access and evidence generation.
ProductLife Group was supported by a Franco-Spanish team led by Eric Fougedoire, Guy Richard Wallis, Victor Schrijner, and Rocio Vivo, RSM partners.
Following the acquisitions of Zwiers Regulatory Consultancy, Cilatus, Intexo, Strategiqual, and LifeBee,this marks the sixth European external growth operation entrusted to RSM’s Corporate Finance division.
Through this transaction, RSM's Corporate Finance division strengthens its role as an expert in the life sciences sector during strategic acquisitions in the market.
ProductLife Group (PLG), a global provider of regulatory, scientific, compliance, and digital transformation consulting services for the life sciences industry, is pleased to announce the acquisition of Outcomes’10,a leading Spanish life sciences consulting company specializing in patient access and evidence generation.
Founded 15 years ago, Outcomes’10 is a trusted partner for its reliable and comprehensive market access services in Spain, including pricing and reimbursement, health economics, outcomes studies, and real-world evidence generation. This acquisition comes less than a year after the acquisitions of Intexo in Italy and Commercial Eyes in Australia and will support PLG’s ambition to build a global market access offering. This expanded platform will leverage synergies and offer comprehensive access services to PLG’s clients, complementing other regulatory consulting services.
Luis Lizán, Founder and CEO of Outcomes’10, said: “Joining PLG is a strategic step for Outcomes’10, our team, and our clients. This partnership aligns with our commitment to professional and operational excellence, allowing us to continue innovating and offering cutting-edge solutions. By becoming part of PLG, we will strengthen strategic relationships and expand growth opportunities for both personal and professional development. Additionally, this collaboration is crucial as the demand for international market access services grows, driven by rapid innovation in health sciences and evolving global regulations. We look forward to expanding our global reach and enhancing our services through this partnership.”
Xavier Duburcq, CEO of PLG, emphasized: “Integrating Outcomes’10 into PLG not only strengthens our service offerings but also increases our competitive advantage in the European market. Outcomes’10 brings a deep understanding of the Spanish market, which will be essential in tailoring our strategies to the diverse regional needs. This alliance will enable us to provide more nuanced and effective market access solutions, ensuring that we can navigate the complexities of different healthcare systems with precision.”
Mariangela Prada, Head of Market Access at PLG, added: “The acquisition of Outcomes’10 is an important next step for the growth and development of our global market access team, thanks to their solid expertise and deep knowledge of the Spanish context.”
The RSM team
The RSM team involved included:
- Financial, legal, and human resources due diligence : Eric Fougedoire, Guy Richard Wallis, Victor Schrijner, Rocio Vivo.
